Market Place
Sourcing Support
All News #Library
Biotech
Enveda`s Oral Therapy Breakthrough in Atopic Dermatitis
06 Apr 2026 //
INDPHARMAPOST
Enveda Launches Phase 1 Trial For First-In-Class Oral IBD Therapy
24 Dec 2025 //
INDPHARMAPOST
Enveda Secures FDA Clearance for Third IBD Asset in Clinic
23 Dec 2025 //
BUSINESSWIRE
Enveda Announces ENV-308 IND Clearance, Appoints Sarwar as CSO
17 Dec 2025 //
BUSINESSWIRE
Enveda Launches Phase 2 of ENV-294 for Atopic Dermatitis, Asthma
09 Dec 2025 //
BUSINESSWIRE
Enveda Secures Additional $150M to Advance Nature-Inspired Drugs
04 Sep 2025 //
FIERCE BIOTECH
Enveda Reports Favorable Phase 1 Safety, Launches Phase 1b Trial
28 May 2025 //
BUSINESSWIRE
Enveda Expands into Asthma with ENV-294 & Assembles Advisory Board
05 Feb 2025 //
BUSINESSWIRE
Enveda Announces 1st AI-Discovered Drug Candidate in Clinical Trial
13 Nov 2024 //
BUSINESSWIRE
Enveda Biosciences Hires CMO To Advance Clinical Pipeline
01 Aug 2024 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.